NRX Pharmaceuticals, Inc.: Form 8-K, filed Jan 14, 2025
Filed with the SEC on Jan 14, 2025 and accepted by EDGAR at Jan 14, 2025, 16:12 ET.
Items reported
- Item 5.02 Departure or appointment of officers or directors
- Item 8.01 Other events
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001437749-25-001113. Last ingested by Listed: Nov 5, 2026, 19:01 ET. Listed shows no prices and gives no investment advice.